 Most of us here today are lucky. We are lucky because we can benefit from standardized registered drugs, and they are safe and effective for us. But for others, these same drugs can be inefficient, dangerous and even lethal due to genetic differences, age and clinical conditions. All of us here know someone who would benefit from personalized medicines at some point of their lives. Let's start with the fact. Did you know that 50% of medicines are not available in doses suitable for children? And children are not the only ones in need of tailored treatments. They are crucial for some of the most sensitive patient groups, including cancer patients, patients with chronic disorders, clinical diseases, animals, the elderly. 50% of elderly people have swallowing problems and would benefit from personalized medicines. While there is a significant clinical need for personalized medicines, today only 1% of medicines are personalized. The process of personalizing medicines has remained largely unchanged for the past 2,000 years. Pharmacies are still manually mixing ingredients in a process known as compounding. compounding, however, is slow, expensive and prone to human errors. You know what can happen when you are baking a cake and you are supposed to put in two eggs, but you put in three. Compounding includes only limited quality control, and this can lead to fatal human errors related to contamination of drugs or incorrect dosing. But guess what? We are on a verge of a breakthrough. Compounding may have served its purpose in the past, but it's time for better ways to personalize medicines. And this is the problem we started solving together with CuriFi Labs, and allow me to introduce my co-founder, Niklas, together with his mother, Helena. Helena used to be a hospital pharmacist, and she inspired Niklas to become a pharmacist and later also a professor in pharmaceutical technology. Niklas realized that 3D printing could be the solution to personalizing medicines in the future. 3D printing allows tailored dosage forms in small batches close to the patient. Our solution is called the Pharma Kit, and it includes everything a pharmacy needs for replacing current manufacturing methods. While 3D printing is part of the solution, our service also is based on printable pharma inks, and that's the real IP in the business. You can think of them a bit like when you are printing on paper, you need also ink for that. So printing is impossible without them. Our printable inks allow tailoring of dose, size, taste and dosage form, catering the unique needs from newborns to elderly, even animals. They are compatible with most essential drug substances, making them incredibly versatile. We have also developed user-friendly software as well as in-process quality control tools. The Pharma Kit is a perfect solution offering a scalable and safe technology for replacing current manufacturing methods. So why should you be excited about this? And why would a pharmacy pay? The Curify Labs technology, the Pharma Kit, allows better medication safety at significantly lower cost. It's a win-win for healthcare providers and patients alike. In fact, our technology is already used and saves money, which saves time. They fall U.S.-based compounding pharmacies and hospital pharmacies would automate their compounding process. It would save costs with $500 million each year. We are tapping into an existing market, which is growing. And this is good because of three reasons. One, we can predict the market growth. Two, there are already existing regulations, meaning that there are no regulatory hurdles. We are simply applying a new technology to an existing need. Three, due to the global shortage of healthcare providers, the world is running out of pharmacists. We need to solve this somehow, and we have the solution. This is also why our technology is making waves on nine different markets, and key opinion leader hospitals are endorsing our efforts. We have already witnessed the positive impacts of our technology in patients who have been treated. We are proud to have the backing of experienced investors, and we have also secured the EIC grant of 2.5 million euros. And who knows, maybe here at Slush, there are some investors who would like to join our journey. So, I said in the beginning that most of us here today are lucky. But remember, at least 10% of patients would benefit from personalized medicines. Our technology doesn't just benefit patients through better treatments. It empowers pharmacists and doctors through time savings. The healthcare system with improved efficiency, lower healthcare costs, shorter stays at hospital, and thus the society as a whole. We are shaping a future where personalized medicines becomes the norm. Because all of us know someone who would benefit from personalized medicines at some point of their lives. Follow our journey, get in touch, and to all investors out there, I really hope to see you on the dance floor later tonight. Thank you.